Vanda Pharmaceuticals, Inc. (VNDA)
6.60
-0.15
(-2.22%)
USD |
NASDAQ |
Dec 11, 16:00
6.63
+0.03
(+0.45%)
After-Hours: 18:56
Vanda Pharmaceuticals Research and Development Expense (TTM): 100.10M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 344.78M |
| ADMA Biologics, Inc. | 3.776M |
| Aldeyra Therapeutics, Inc. | 35.99M |
| Exelixis, Inc. | 860.76M |
| Anavex Life Sciences Corp. | 37.59M |